The purpose of this Limited Competition is to extend the Cure Glomerulonephropathy (CureGN) Network by continuing to support the Participating Clinical Centers (PCCs).
The CureGN Network is a multicenter observational cohort study of glomerular disease patients with the goal of improving care
for all glomerular disease patients.
The CureGN PCCs will continue to follow-up previously enrolled participants and enroll a limited number of new participants.
The primary objective of the PCCs will be to optimize retention strategies, and methods for "remote" or "virtual" study participation; ensure complete and accurate data and biosample collection with a focus on clinical assessment of disease activity and outcomes.
The DCC, under a separate NOFO, provides key leadership functions for this study in the areas of study organization, study design and implementation, and biosample management.